Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Lay Summaries and Lay Summary Videos

  • TRIJARDY® XR - Healthy
    Clinical Study Number 1361-0011
    Study Indication Healthy
    Product TRIJARDY® XR
    Generic Name Empagliflozin + Linagliptin + Metformin
    Lab Code
    Clinical Phase I
    Study Title

    Bioequivalence of a low strength fixed dose combination tablet of empagliflozin/linagliptin/metformin extended release compared to the free combination of empagliflozin, linagliptin, and metformin extended release tablets following oral administration in healthy male and female subjects (an open-label, randomised, single-dose, two-period, two-sequence crossover study)

    Study Document
    Lay summary 1361-0011 english